GLAXOSMITH Stock Overview
GlaxoSmithKline Consumer Nigeria Plc manufactures, markets, and distributes of consumer healthcare and pharmaceutical products in Nigeria, Africa, the Middle East, the Americas, the Asia Pacific, and Europe. More details
| Snowflake Score | |
|---|---|
| Valuation | 1/6 |
| Future Growth | 0/6 |
| Past Performance | 2/6 |
| Financial Health | 6/6 |
| Dividends | 3/6 |
My Notes
Capture your thoughts, links and company narrative
GlaxoSmithKline Consumer Nigeria Plc Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | ₦17.00 |
| 52 Week High | ₦17.05 |
| 52 Week Low | ₦6.00 |
| Beta | 0.15 |
| 1 Month Change | 1.19% |
| 3 Month Change | 5.92% |
| 1 Year Change | 165.63% |
| 3 Year Change | 144.60% |
| 5 Year Change | 41.67% |
| Change since IPO | 290.63% |
Recent News & Updates
Recent updates
Shareholder Returns
| GLAXOSMITH | NG Pharmaceuticals | NG Market | |
|---|---|---|---|
| 7D | 0% | 1.6% | 1.9% |
| 1Y | 165.6% | -7.8% | 53.2% |
Return vs Industry: GLAXOSMITH exceeded the NG Pharmaceuticals industry which returned 17.5% over the past year.
Return vs Market: GLAXOSMITH exceeded the NG Market which returned 108.1% over the past year.
Price Volatility
| GLAXOSMITH volatility | |
|---|---|
| GLAXOSMITH Average Weekly Movement | 2.0% |
| Pharmaceuticals Industry Average Movement | 6.9% |
| Market Average Movement | 6.1% |
| 10% most volatile stocks in NG Market | 8.8% |
| 10% least volatile stocks in NG Market | 3.1% |
Stable Share Price: GLAXOSMITH's share price has been volatile over the past 3 months.
Volatility Over Time: GLAXOSMITH's weekly volatility has decreased from 7% to 2% over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1971 | 51 | Olakunle Oyelana | www.gsk.com/ng |
GlaxoSmithKline Consumer Nigeria Plc manufactures, markets, and distributes of consumer healthcare and pharmaceutical products in Nigeria, Africa, the Middle East, the Americas, the Asia Pacific, and Europe. It operates through two segments, Consumer Healthcare and Pharmaceuticals. The Consumer Healthcare segment offers oral care, over the counter (OTC) medicines, and nutritional healthcare products.
GlaxoSmithKline Consumer Nigeria Plc Fundamentals Summary
| GLAXOSMITH fundamental statistics | |
|---|---|
| Market cap | ₦20.33b |
| Earnings (TTM) | ₦735.69m |
| Revenue (TTM) | ₦15.85b |
27.6x
P/E Ratio1.3x
P/S RatioIs GLAXOSMITH overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| GLAXOSMITH income statement (TTM) | |
|---|---|
| Revenue | ₦15.85b |
| Cost of Revenue | ₦10.62b |
| Gross Profit | ₦5.23b |
| Other Expenses | ₦4.49b |
| Earnings | ₦735.69m |
Last Reported Earnings
Sep 30, 2023
Next Earnings Date
n/a
| Earnings per share (EPS) | 0.62 |
| Gross Margin | 33.00% |
| Net Profit Margin | 4.64% |
| Debt/Equity Ratio | 0% |
How did GLAXOSMITH perform over the long term?
See historical performance and comparisonDividends
3.2%
Current Dividend Yield89%
Payout RatioCompany Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2024/02/09 07:42 |
| End of Day Share Price | 2024/02/09 00:00 |
| Earnings | 2023/09/30 |
| Annual Earnings | 2022/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .
Analyst Sources
GlaxoSmithKline Consumer Nigeria Plc is covered by 4 analysts. of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| Omotayo Oyegunle | CSL Stockbrokers Ltd |
| null null | FSDH Merchant Bank Limited |
| null null | Meristem Securities Limited |